Dr. Amber Noman

2023 Haneef K, Salim A, Hashim Z, Ilyas A, Syed B, Ahmed A, Zarina S (2023) Chemical Hypoxic Preconditioning Improves Survival and Proliferation of Mesenchymal Stem Cells. Appl Biochem Biotechnol.
2023 Tanveer F, Ilyas A, Syed B, Hashim Z, Ahmed A, Zarina S (2023) Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach. Appl Biochem Biotechnol.
2021 Mohsin, A., Haneef, K., Ilyas, A., Zarina, S., & Hashim, Z. (2021). Oxidative Stress Induced Cell Cycle Arrest: Potential Role of PRX-2 and GSTP-1 as Therapeutic Targets in Hepatocellular Carcinoma. Protein and Peptide Letters, 28(12), 1323-1329.
2021 Usman, M., Ilyas, A., Syed, B., Hashim, Z., Ahmed, A., & Zarina, S. (2021). Serum HSP90-alpha and oral squamous cell carcinoma: a prospective biomarker. Protein and Peptide Letters, 28(10), 1157-1163.
2021 Rashid, S., Qazi, R. E. M., Malick, T. S., Salim, A., Khan, I., Ilyas, A., & Haneef, K. (2021). Effect of valproic acid on the hepatic differentiation of mesenchymal stem cells in 2D and 3D microenvironments. Molecular and Cellular Biochemistry476(2), 909-919.
2020 Hashim, Z., Ilyas, A., & Zarina, S. (2020). Therapeutic effect of hydrogen peroxide via altered expression of glutathione S-transferase and peroxiredoxin-2 in hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International, 19(3), 258-265.
2020 Usman, M., Ilyas, A., Hashim, Z., & Zarina, S. (2020). Identification of GIMAP7 and Rabl3 as putative biomarkers for oral squamous cell carcinoma through comparative proteomic approach. Pathology & Oncology Research, 26(3), 1817-1822.
2020 Syed, N., Ilyas, A., Idrees, F., Zarina, S., & Hashim, Z. (2020). Inhibition of USP2 Induces apoptosis through down regulation of fatty acid synthase and Cyclin D1 in triple negative breast cancer. Current Proteomics, 17(5), 425-432.
2020 Usman, M., Tanveer, F., Ilyas, A., & Zarina, S. (2020). Varlitinib Mediates Its Activity Through Down Regulating MAPK/EGFR Pathway in Oral Cancer. Current Proteomics17(1), 51-58.
2020 Malik, U. U., Siddiqui, I. A., Ilyas, A., Hashim, Z., Staunton, L., Kwasnik, A., … & Zarina, S.(2020). Identification of differentially expressed proteins from smokeless tobacco addicted patients suffering from Oral squamous cell carcinoma. Pathology & Oncology Research, 26(3), 1489-1497.
2019 Syed, N., Ilyas, A., Zarina, S., & Hashim, Z. (2019). Assessment of Anticancer Effect of Alendronate in Breast Cancer: An In vitro Study. J. Biotech. Biomed. Sci, 2(2), 1-7.
2018 Ilyas, A., Hashim, Z., Channa, I. S., & Zarina, S. (2018). Alendronate and FTI-277 combination as a possible therapeutic approach for hepatocellular carcinoma: An in vitro study. Hepatobiliary & Pancreatic Diseases International, 17(3), 241-250.
2016 Atta, A., Ilyas, A., Hashim, Z., & Zarina, S. (2016). Structure Function Relationship of Lactate Dehydrogenase/[epsilon]-Crystallin from Lenses of Indian Spiny-Tailed Lizard (Uromastyx hardwickii). Pakistan Journal of Zoology, 48(4), 1147-1153.
2015 Ilyas, A., Hashim, Z., & Zarina, S. (2015). Effects of 5′-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective. Molecular and Cellular Biochemistry, 405(1), 53-61.
2014 Atta, A., Ilyas, A., Hashim, Z., Ahmed, A., & Zarina, S. (2014). Lactate dehydrogenase like crystallin: A potentially protective shield for Indian spiny-tailed lizard (Uromastyx hardwickii) lens against environmental Stress?. The protein journal, 33(2), 128-134.
2014 Ilyas, A., Hashim, Z., Naeem, N., Haneef, K., & Zarina, S. (2014). The effect of alendronate on proteome of hepatocellular carcinoma cell lines. International Journal of proteomics, 2014, 0-9.
2009 Hashim, Z., Ilyas, A., Saleem, A., Salim, A., & Zarina, S. (2009). Expression and activity of paraoxonase 1 in human cataractous lens tissue. Free Radical Biology and Medicine, 46(8), 1089-1095.
2009 Sahar, N., Ahmed, M., Parveen, Z., Ilyas, A., & Bhutto, A. (2009). Screening of mycotoxins in wheat, fruits and vegetables grown in Sindh, Pakistan. Pak J bot41(1), 337-341.